Late-breaking Trials from the 2016 American Heart Association's Scientific Sessions

Kyle D. Buchanan, M. Chadi Alraies, Alexandre H. Kajita, Toby Rogers, Edward Koifman, Arie Steinvil

Research output: Contribution to journalReview articlepeer-review


The late breaking trials released at the American Heart Association scientific sessions conference in November in New Orleans, LA covered a wide range of topics, including new devices within the field of heart failure, new registry data on transcatheter aortic valve replacement (TAVR) in intermediate risk patients, and medical management of peripheral arterial disease, coronary artery disease, and hypercholesterolemia. The following review highlights the late breaking trials presented at the conference that will have significant impact on clinical practice.

Original languageEnglish
Pages (from-to)70-74
Number of pages5
JournalCardiovascular Revascularization Medicine
Issue number1
StatePublished - 1 Jan 2017
Externally publishedYes


  • Atrial fibrillation
  • Coronary artery disease
  • Heart failure
  • Transcatheter aortic valve replacement


Dive into the research topics of 'Late-breaking Trials from the 2016 American Heart Association's Scientific Sessions'. Together they form a unique fingerprint.

Cite this